Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein

被引:115
|
作者
Gout, I
Middleton, G
Adu, J
Ninkina, NN
Drobot, LB
Filonenko, V
Matsuka, G
Davies, AM
Waterfield, M
Buchman, VL
机构
[1] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland
[2] Ludwig Inst Canc Res, London W1P 8BT, England
[3] Inst Mol Biol & Genet, UA-252143 Kiev, Ukraine
[4] HV Palladin Inst Biochem, UA-290005 Lvov, Ukraine
[5] Russian Acad Sci, Inst Gene Biol, Moscow, Russia
来源
EMBO JOURNAL | 2000年 / 19卷 / 15期
关键词
adaptor protein; neuronal apoptosis; phosphoinositide; 3-kinase; signal transduction;
D O I
10.1093/emboj/19.15.4015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Class I-A phosphatidylinositol 3-kinase (PI3-kinase) is a key component of important intracellular signalling cascades. We have identified an adaptor protein, Ruk(1), which forms complexes with the PI 3-kinase holoenzyme in vitro and in vivo. This interaction involves the proline-rich region of Ruk and the SH3 domain of the p85 alpha regulatory subunit of the class I-A PI 3-kinase. In contrast to many other adaptor proteins that activate PI 3-kinase, interaction with Ruk(1) substantially inhibits the lipid kinase activity of the enzyme. Overexpression of Ruk(1) in cultured primary neurons induces apoptosis, an effect that could be reversed by co-expression of constitutively activated forms of the p110 alpha a catalytic subunit of PI 3-kinase or its downstream effector PKB/Akt, Our data provide evidence for the existence of a negative regulator of the PI 3-kinase signalling pathway that is essential for maintaining cellular homeostasis. Structural similarities between Ruk, CIN85 and CD2AP/CMS suggest that these proteins form a novel family of adaptor molecules that are involved in various intracellular signalling pathways.
引用
收藏
页码:4015 / 4025
页数:11
相关论文
共 50 条
  • [1] Regulation of protein kinase C ζ by PI 3-kinase and PDK-1
    Chou, MM
    Hou, WM
    Johnson, J
    Graham, LK
    Lee, MH
    Chen, CS
    Newton, AC
    Schaffhausen, BS
    Toker, A
    CURRENT BIOLOGY, 1998, 8 (19) : 1069 - 1077
  • [2] Unique phosphorylation mechanism of Gab1 using PI 3-kinase as an adaptor protein
    Onishi-Haraikawa, Y
    Funaki, M
    Gotoh, N
    Shibuya, M
    Inukai, K
    Katagiri, H
    Fukushima, Y
    Anai, M
    Ogihara, T
    Sakoda, H
    Ono, H
    Kikuchi, M
    Oka, Y
    Asano, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (02) : 476 - 482
  • [3] Role of RAS in the Regulation of PI 3-Kinase
    Castellano, Esther
    Downward, Julian
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 143 - 169
  • [4] PI 3-kinase regulation of dopamine uptake
    Carvelli, L
    Morón, JA
    Kahlig, KM
    Ferrer, JV
    Sen, N
    Lechleiter, JD
    Leeb-Lundberg, LMF
    Merrill, G
    Lafer, EM
    Ballou, LM
    Shippenberg, TS
    Javitch, JA
    Lin, RZ
    Galli, A
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 (04) : 859 - 869
  • [5] PI 3-kinase
    Krugmann, S
    Welch, H
    CURRENT BIOLOGY, 1998, 8 (23) : R828 - R828
  • [6] Mechanism involved in the regulation of the novel class II phosphoinositide 3-kinase (PI3K-C2α) by protein kinase c
    Ktori, C
    Shepherd, PR
    DIABETES, 2002, 51 : A599 - A599
  • [7] Activation of PI 3-kinase by G protein βγ subunits
    Hazeki, O
    Okada, T
    Kurosu, H
    Takasuga, S
    Suzuki, T
    Katada, T
    LIFE SCIENCES, 1998, 62 (17-18) : 1555 - 1559
  • [8] PI 3-kinase, mTOR, protein synthesis and cancer
    Vogt, PK
    TRENDS IN MOLECULAR MEDICINE, 2001, 7 (11) : 482 - 484
  • [9] XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway
    M Lodyga
    V De Falco
    X-h Bai
    A Kapus
    R M Melillo
    M Santoro
    M Liu
    Oncogene, 2009, 28 : 937 - 949
  • [10] Characterization of a novel PI 3-kinase associated serine kinase distinct from PI 3-kinase.
    Cengel, KA
    Godbout, J
    Nolan, P
    Freund, GG
    DIABETES, 1997, 46 : 1082 - 1082